ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype -WAYNE, Pa., (GLOBE ...

Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body. The earlier you seek treatment, the better your chances of maintaining your ...

Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, outperforming Pfizer's Litfulo in a severe hair loss mouse model.

TAMPA (BLOOM) – Alopecia Universalis (AU) stands as one of the most severe forms of hair loss, yet it remains shrouded in mystery. This condition doesn’t just result in the loss of scalp hair but ...

The findings add confidence to the role of ritlecitinib as a treatment option for severe alopecia areata while pointing the way toward more personalized approaches. The kinase inhibitor ritlecitinib ...